Minority Health and Health Disparities Research

Active

Assistance listing
93.307
Agency
Grant awards
2,135 $9,385,264,532 in federal obligations

Program facts

Assistance types
  • Project Grant
  • Cooperative Agreement
  • Block Grant
Treasury account
  • 75-0897-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The National Institute on Minority Health and Health Disparities (NIMHD) within the National Institutes of Health funds research under CFDA 93.307 to support basic, clinical, social, and behavioral research addressing minority health and health disparities, with the most recent award issued on September 3, 2026. The program has funded 2,135 awards since 1986, with consistent activity: 227 awards in 2022, 188 in 2023, 165 in 2024, 49 in 2025, and 90 in 2026.

The portfolio is predominantly Project Grants (93% of awards), with smaller shares of Cooperative Agreements (5%) and Block Grants (2%). The National Institute for Minority Health and Health Disparities dominates funding, accounting for 1,629 awards totaling $7.97 billion in federal dollars obligated—76% of all award count and 85% of federal dollars. The NIH broadly and the Department of Health and Human Services contribute smaller shares; 16 distinct federal funding agencies participate overall, though the remaining funders represent marginal activity.

Combined federal obligations total $9.39 billion, with combined total obligated (including recipient cost-share) at $9.79 billion. Recent awards show typical magnitudes in the $500 thousand to $2 million range, with notable exceptions: a $3.12 million award to implement AI-tailored home-based cervical and colorectal cancer screening for American Indian/Alaska Native populations; a $1.46 million award examining housing transitions and health outcomes for persons experiencing homelessness; and a $3.91 million Cooperative Agreement to North Carolina A&T for a Research Centers in Minority Institutions program addressing brain health and cardiometabolic diseases in African American populations.

Recent awards target concrete health challenges: kidney disease screening and management in federally qualified health centers; dialysis facility expansion and disparities in end-stage kidney disease outcomes; dual-platform plasma assays for early lung cancer detection in African Americans; school meal reforms and children's nutrition; telemedicine-enabled guideline-directed medical therapy for rural heart failure patients; and maternal health interventions tailored to Native Hawaiian and Pacific Islander communities.

No recently posted grant opportunities remain open with active submission dates. Several forecasted opportunities are under development, including limited competitions for the John Lewis NIMHD Research Endowment Program (posted September 8, 2026) and innovations in Native Hawaiian and Pacific Islander health outcomes (RFA-MD-27-004, posted August 25, 2026). Broader parent solicitations such as the Investigator-Focused Award (R35), Research Program Projects (P01), and SBIR/STTR programs remain available through standard NIH mechanisms with extended due dates extending into 2027–2029.

Objective and description

Objective

To support basic, clinical, social, and behavioral research; promote research infrastructure and training; foster emerging programs; disseminate information; and reach out to minority and other health disparity communities. The National Institute on

Description

The National Institute on Minority Health and Health Disparities (NIMHD) mission is to lead scientific research to improve minority health and reduce health disparities. To accomplish this, NIMHD plans, coordinates, reviews, and evaluates NIH minority health and health disparities research and activities, conducts and supports research in minority health and health disparities, promotes and supports the training of a diverse research workforce, translates and disseminates research information and fosters innovative collaborations and partnerships.

Eligibility

Applicant eligibility

Individuals and public and private institutions, both non-profit and for-profit, who propose to establish, expand, and conduct research, promote or engage in research training, and outreach activities that contribute to improving minority health and/or eliminating health disparities. Endowment grants: Only NIMHD Centers of Excellence or Section 736 health professional schools (see 42 U.S.C. 293) with net endowment assets less than or equal to 50 percent of the national median of endowment funds at institutions that conduct similar biomedical research or training of health professionals are eligible for the research endowment awards. All applicants must have an NIMHD Center of Excellence Award or HRSA Centers of Excellence Award at the time of award of an NIMHD Research Endowment Grant. SBIR grants: Domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which the research is proposed, and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. Small business concerns must be at least 51 percent US owned by individuals and independently operated and/or at least 51 percent owned and controlled by another (one) for-profit business concern that is at least 51 percent owned and controlled by one or more individuals. The research must be performed in the U.S. or its possessions. STTR grants: Domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which the research is proposed, and have no more than 500 employees) that "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution.

Beneficiary eligibility

Any non-profit or for-profit organization, company, or institution engaged in biomedical and behavioral research. Endowment grants: NIMHD Centers of Excellence or Section 736 institutions.

Credentials and documentation

Applicants must present a research plan and furnish evidence required for research grant applications, PHS 398, (Rev. 05/01) as specified in the application form. Costs will be determined in accordance with HHS Regulation 45 CFR 75, as applicable, and the NIH Grants Policy Statement (http://grants.nih.gov/grants/policy/nihgps/index.htm), which is a term and condition of all NIH grant awards. For-profit organizations' costs are determined in accordance with Subpart 31.2 of the Federal Acquisition Regulations. Endowment grants: Requirements for the endowment application are specified in the application form (SF424 R & R). SBIR and STTR grants: Applicant organizations (small business concerns) must present a research plan that includes an idea that has the potential for commercialization, and furnish evidence that the scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. To apply for SBIR Phase I and Phase II Grants, applicants must complete SF424 (R & R) Application for Electronic Submission. For general information on SF424 (R & R) Application and Electronic Submission, see these Web sites: SF424 (R & R) Application and Electronic Submission Information: https://grants.nih.gov/grants/how-to-apply-application-guide/forms-f/general/g.100-how-to-use-the-application-instructions.htm. General information on Electronic Submission of Grant Applications: http://grants.nih.gov/grants/ElectronicReceipt/.

Uses of assistance

Grants are intended to support the direct costs of a project in accordance with an approved budget, plus appropriate amount for indirect costs. Grantees must agree to administer the grant in accordance with the regulations and policies governing the research grants program of the Public Health Service. Endowment grants: Some qualifying institutions may use income earned from a research endowment corpus to support institutions in their effort to expand and add teaching programs in the biomedical and behavioral sciences and related areas, to improve facilities, to enhance student and faculty recruitment and retention, to develop instructional delivery systems and information technology in areas that will enhance minority health and other health disparities research activities, and to establish endowed chairs and programs. Other qualifying institutions must use income earned from a research endowment corpus to increase the institutions' investments in the recruitment and retention of underrepresented minority students and students from other health disparity populations that matriculate at such institutions. This includes activities such as increasing student recruitment and retention, creating merit-based and need-based scholarships, establishing or enhancing tutoring, providing counseling, and designing student service programs to improve academic success, and faculty recruitment and retention. SBIR grants: SBIR Phase I grants are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. SBIR Phase II grants are for the continuation of the research initiated in Phase I and are likely to result in commercial products or processes. Only Phase I awardees are eligible to apply for Phase II support. STIR grants: STTR Phase I grants are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. STTR Phase II grants are based on results of research initiated in Phase I and scientific and technical merit and commercial potential on Phase II application. See applicable funding opportunity announcements for specifics. (Grants.nih.gov)

Length and time phasing of assistance

All awards have a project period of one to five years. Non-competitive grant awards in successive years (year 2 up to year 5) are awarded based on the applicant's annual performance and the availability of funds. SBIR grants: Generally, Phase I awards are for six months, and Phase II awards are for two years. STTR grants: Generally, Phase I awards are for one year, and Phase II awards are for two years. All funds for any award must be obligated within five years from the date of the award. See the following for information on how assistance is awarded/released. See individual funding opportunity announcements as published in the NIH Guide: https://grants.nih.gov/funding/searchguide/index.html#/.

How to apply

Application procedure

Applications for the various programs should be submitted to the NIH office that is responsible for the receipt of applications, and in such form and manner as the application prescribes. (All information pertaining to grants hereinafter, also apply to Endowment Grants unless otherwise noted). Research Grants: Applications must be prepared electronically through Grants.gov (http://www.grants.gov) using the SF 424 (Research and Research-Related). Visit the following link to obtain application information and instructions for all applications types including fellowships, SBIR/STTR (https://grants.nih.gov/grants/how-to-apply-application-guide.html). Application must be made electronically through grants.gov (http://www.grants.gov). For further assistance contact Grants Info, Telephone: (301) 435-0714, Email: Grantslnfo@nih.gov.

Criteria for selecting proposals

The major elements in evaluating all new grant and renewal grant applications include assessments of the scientific merit and general significance of the proposed study and its objectives; the technical adequacy of the experimental design and approach; the competency of the proposed investigator or group to successfully pursue the project; the adequacy of the available and proposed facilities and resources; and the necessity of the budget components requested in relation to the proposed project and the relevance and importance to the announced program objectives. SBIR and STTR grants: For Phase I grant applications, the criteria used are the soundness and technical merit of the proposed approach; the qualifications of the proposed principal investigator, supporting staff, and consultants; the technological innovation of the proposed research; the potential of the proposed suitability of the facilities and research environment; and where applicable, the adequacy of assurances detailing the proposed means for safeguarding human or animal subjects and/or protecting against or minimizing any adverse effect on the environment. For Phase II grant applications, the criteria used are the degree to which the Phase I objectives were met and feasibility demonstrated; the scientific and technical merit of the proposed approach for achieving the Phase II objectives; the qualifications of the proposed principal investigator, supporting staff and consultants; the technological innovation, originality, or societal importance of the proposed research; the potential of the proposed research for commercial application; the reasonableness of the budget requested for the work proposed; the adequacy and suitability of the facilities and research environment; and, where applicable, the adequacy of assurances detailing the proposed means for safeguarding human or animal subjects and/or protecting against or minimizing any adverse effect on the environment. All persons interested in any of the DHHS/NIH/NIMHD grant and/or contract program initiatives are strongly encouraged to carefully read the Request for Applications as they are announced annually in order to understand what is required for each unique program as well as meet each deadline in a timely manner.

Award procedure

Each eligible application will be evaluated for scientific and technical merit by an appropriate Scientific Review Group in accordance with NIH policies and procedures. The National Advisory Council on Minority Health and Health Disparities (NACMHD) will conduct the second-level review of the applications.

Time to approval or disapproval

Approximately 6 to 9 months. SBIR and STTR grants: Approximately 7 to 8 months.

Renewals

Renewal of grant awards beyond the initial project period of support is contingent upon successful competition by the applicant and upon the appropriation of funds for this purpose.

Appeals

A principal investigator or applicant may question the substantive or procedural aspects of the review of his/her application by communicating with NIMHD staff. A description of the NIH Peer Review Appeal procedures is available on the NIH home page http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Grant opportunities

Opportunity Status Posted Applications due
Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed) RFA-MD-28-001 Forecasted —
Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional) RFA-MD-27-004 Forecasted —
Investigator-Focused Award (Parent R35) PAR-28-037 Forecasted —
Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional) RFA-MD-27-001 Forecasted —
NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 Open
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR-27-076 Open
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 Open
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) PAR-28-090 Open
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) PAR-27-090 Open
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
Limited Competition: Social, Behavioral, & Economic (SBE) Coordinating Center RFA-AG-26-005 Past —
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) PAR-27-096 Open
Forecast to Publish a Funding Opportunity Announcement for EmbraceHealth Clinical Research Network to Reduce Health Disparities - Coordinating Center FOR-MD-25-009 Past —
Notice of Intent to Publish a Forecast for EmbraceHealth Clinical Research Network to Reduce Health Disparities - Research Sites FOR-MD-25-008 Past —
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 Open
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 Open
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 Open
Forecast to Publish a Funding Opportunity Announcement for Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) FOR-MD-25-004 Past —
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) PAR-27-077 Open
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) RFA-OD-27-008 Open
Forecast to Publish a Notice of Funding Opportunity Announcement for Addressing Determinants of Health Disparities Among Rural Populations (R01 - Clinical Trial Optional) FOR-MD-25-003 Past —
Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required) FOR-MD-25-005 Past —
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) PAR-25-415 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) PAR-27-015 Open
Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional) RFA-MD-26-001 Closed
Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research Centers FOR-MD-25-002 Past —
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study - Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed) RFA-DA-27-014 Closed
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) PAR-25-414 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-425 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) PA-25-422 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) PA-25-423 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-426 Open
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites (Collaborative U01- Clinical Trial Not Allowed) RFA-DA-27-013 Closed
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-25-379 Open
Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) RFA-HL-26-010 Closed
Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed) RFA-HL-26-009 Closed
Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) RFA-HL-26-011 Closed
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) PAR-25-342 Closed
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) PAR-25-371 Open
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) PAR-25-377 Closed
Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional) RFA-EY-25-002 Closed
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) PA-25-304 Open
NIH Research Project Grant (Parent R01 Clinical Trial Required) PA-25-305 Open
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 Open
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) PA-25-303 Closed
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) PA-25-306 Open
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
Uneven geographic distribution of dialysis facility expansion and its differential impact on health outcomes among… R01DK149058 National Bureau Of Economic Research Inc. $2,159,469
Enhancing kidney care in community health centers (enrich) R01DK147266 University Of Washington $2,938,266
HEALTH360X.AI: accelerating access to medical breakthroughs at the point of care R44MD021394 Accuhealth Technologies Incorporated $311,977
Dual-platform plasma assay for early lung cancer detection in african americans R43MD021361 Biotarget DX LLC $295,924
Exploratory evaluation of labor-associated inflammatory profiles in low-risk nulliparous subgroups during induced and… R21MD021640 Vanderbilt University $217,950
Improving engagement in post-injury mental health care through community health worker-enhanced trauma recovery… R21MD021589 The Medical University Of South Carolina $226,500
A generalizable framework for the development of a continuous metabolic syndrome risk score in small populations. R21MD021564 University Of Alabama At Birmingham $201,362
Transforming rural health: strategies for effective mobile health clinic deployment - rural communities in southwest… R21MD021283 SAM Houston State University $218,160
Empowering nutrition through graphic-style stories: CO-designing an acceptable and feasible community-based program… R21MD020828 Cincinnati Univ Of $202,500
Development of a culturally tailored sleep intervention using artificial intelligence for filipino immigrants R21MD020471 New York University $203,993

Latest 10 of 2,135 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 551 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $471,140,248
FY2025 $1,087,178,010
FY2024 $1,435,657,924
FY2023 $1,489,400,628
FY2022 $1,066,873,602
FY2021 $661,995,660
FY2020 $296,536,741
FY2019 $266,823,801
FY2018 $258,685,651
FY2017 $240,185,364
FY2016 $234,549,365
FY2015 $228,053,095
FY2014 $230,958,048
FY2013 $223,681,246
FY2012 $236,193,356
FY2011 $178,341,058
FY2010 $156,220,160
FY2009 $148,719,835
FY2008 $52,620,846
FY2007 $88,098,767
Show all 20

Quick answers

What is Assistance Listing 93.307?

Assistance Listing 93.307 is Minority Health and Health Disparities Research, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Minority Health and Health Disparities Research?

Its CFDA number is 93.307: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.307 awarded?

2,135 grant awards under 93.307 have obligated $9,385,264,532 in federal funds to 551 recipients.

Who receives the most funding from 93.307?

The recipients obligated the most under Minority Health and Health Disparities Research are University Of Hawaii ($317,288,704), The Morehouse School Of Medicine, Inc. ($259,793,148) and The Johns Hopkins University ($235,654,750).

How much did 93.307 obligate in fiscal year 2025?

Grants under 93.307 obligated $1,087,178,010 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.307?

33 of the latest 50 opportunities under 93.307 are open or forecasted. The latest, Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed), was posted on September 8, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program